首页> 外文期刊>药学学报:英文版 >Rapid and sensitive liquid chromatography–tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5,5′-oxydimethylenebis (2-furfural) in traditional Chinese medicine injections
【24h】

Rapid and sensitive liquid chromatography–tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5,5′-oxydimethylenebis (2-furfural) in traditional Chinese medicine injections

机译:快速灵敏液相色谱-串联质谱法定量测定中药注射剂中潜在有害物质5,5'-氧二亚甲基双(2-糠醛)

摘要

With the rapid development and wide application of traditional Chinese medicine injection(TCMI), a number of adverse events of some TCMIs have incessantly been reported and have drawn broad attention in recent years. Establishing effective and practical analytical methods for safety evaluation and quality control of TCMI can help to improve the safety of TCMIs in clinical applications. In this study, a sensitive and rapid high-performance liquid chromatography–tandem mass spectrometry(HPLC–MS/MS)method has been developed and validated for the quantitative determination of potentially harmful substance5,5′-oxydimethylenebis(2-furfural, OMBF) in TCMI samples. Chromatographic separation was performed on a C18 reversed-phase column(150 mm × 2.1 mm, 5 μm) by gradient elution, using methanol–water containing 0.1% formic acid as mobile phase at the flow rate of 0.3 m L/min. MS/MS detection was performed on a triple quadrupole mass spectrometer with positive electrospray ionization in the multiple reaction-monitoring mode. The method was sensitive with a limit of quantification of 0.3 ng/m L and linear over the range of 0.3–30 ng/m L(r = 0.9998). Intra-and inter-day precision for analyte was o9.52% RSD withrecoveries in the range 88.0–109.67% at three concentration levels. The validated method was successfully applied to quantitatively determine the compound OMBF in TCMIs and glucose injections. Our study indicates that this method is simple, sensitive, practicable and reliable, and could be applied for safety evaluation and quality control of TCMIs and glucose injections.
机译:随着中药注射剂(TCMI)的快速发展和广泛应用,近年来不断出现一些中药注射剂的不良反应,引起了广泛关注。建立有效,实用的TCMI安全评估和质量控制分析方法可以帮助提高TCMI在临床应用中的安全性。在这项研究中,已开发出灵敏快速的高效液相色谱-串联质谱(HPLC-MS / MS)方法,并已用于定量测定潜在有害物质5,5'-氧二亚甲基双(2-糠醛,OMBF)的方法在TCMI样本中。色谱分离是在C18反相柱(150 mm×2.1 mm,5μm)上通过梯度洗脱进行的,使用含0.1%甲酸的甲醇-水作为流动相,流速为0.3 m L / min。 MS / MS检测是在三重四极杆质谱仪上以正电喷雾电离在多重反应监控模式下进行的。该方法灵敏,定量限为0.3 ng / m L,线性范围为0.3–30 ng / m L(r = 0.9998)。在三个浓度水平下,分析物的日内和日间精度为oSD的o9.52%,回收率在88.0-109.67%范围内。验证的方法已成功应用于定量测定TCMI和葡萄糖注射液中的化合物OMBF。我们的研究表明,该方法简单,灵敏,实用,可靠,可用于TCMI和葡萄糖注射液的安全性评估和质量控制。

著录项

  • 来源
    《药学学报:英文版》 |2018年第2期|P.235-241|共7页
  • 作者单位

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College;

    New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College;

    Centre for Bioimaging & Systems Biology, Minzu University of China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 药品鉴定;
  • 关键词

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号